5-HT3-receptor-associated mechanisms of PONV a risk factor targeted approach to anti-emetic therapy

Journal of Anaesthesiology Clinical Pharmacology

Volumn 26, Issue 1, 2010, Pages 3-10

  Johnston, Kevin D ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

ANESTHETIC AGENT; ANTIEMETIC AGENT; ANTIHISTAMINIC AGENT; ATROPINE; CISPLATIN; CYCLIZINE; DEXAMETHASONE; DOPAMINE; DOPAMINE RECEPTOR BLOCKING AGENT; DROPERIDOL; GLYCOPYRRONIUM BROMIDE; HALOTHANE; INTRAVENOUS ANESTHETIC AGENT; ISOFLURANE; KETAMINE; LOPERAMIDE; METHOHEXITAL; METOCLOPRAMIDE; MORPHINE; MUSCARINIC RECEPTOR; NICOTINE PATCH; ONDANSETRON; OPIATE DERIVATIVE; PROMETHAZINE; PROPOFOL; PROSTAGLANDIN SYNTHASE INHIBITOR; SCOPOLAMINE; SEROTONIN 3 ANTAGONIST; SEROTONIN 3 RECEPTOR; THIOPENTAL;

ANTIEMETIC ACTIVITY; AREA POSTREMA; CHEMOTHERAPY INDUCED EMESIS; CLINICAL TRIAL; DRUG EFFICACY; ELECTROSTIMULATION; GYNECOLOGIC SURGERY; HUMAN; MOTION SICKNESS; NONHUMAN; OPIOID INDUCED EMESIS; POSTOPERATIVE NAUSEA AND VOMITING; POSTOPERATIVE VOMITING; REVIEW; RISK FACTOR; SOLITARY TRACT NUCLEUS;

EID: 76749130582     PISSN: 09709185     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (99)

1. Apfel CC, Läärä E, Koivuranta M, Greim CA, Roewer N. A simplified risk score for predicting postoperative nausea and vomiting: conclusions from crossvalidations between two centers. Anesthesiology 1999; 91: 693-700
2. Gan TJ, Meyer T, Apfel CC et al. Consensus guidelines for managing postoperative nausea and vomiting. Anesth Analg 2003; 97: 62-71
3. Andrews PLR. Approaching an understanding of the mechanism of postoperative nausea and vomiting. In: Strunin L, Rowbotham D, Miles A, Editors. The prevention and management of postoperative nausea and vomiting 2nd ed. London: Aesculapius medical, 2003: 3-28
4. Borison HL, Wang SC. Functional localisation of the central coordinating mechanism for emesis in cat. J Neurophysiol 1949; 12: 304-13
5. Yamamoto K, Ngan MP, Takeda N, Yamatodani A, Rudd JA. Differential activity of drugs to induce emesis and pica behaviour in Suncus murinus (house musk shrew) and rats. Physiol Behav 2004; 83: 151-6
6. Wilkens EP, Yates BJ. Pretreatment with ondansetron blunts plasma vasopressin increases associated with morphine administration in ferrets. Anesth Analg 2005; 101: 1029-33
7. Lau AHY, Ngan MP, Rudd JA, Yew DTW. Differential action of domperidone to modify emesis and behaviour induced by apomorphine in the ferret. Eur J Pharmacol 2005; 516: 247-52
8. Lau AHY, Rudd JA, Yew DTW. Action of ondansetron and CP-99,994 on cisplatin-induced emesis and locomotor activity in Suncus murinus. (house musk shrew) Behav Pharmacol 2005; 16: 605-12
9. Miller AD, Rowley HA, Roberts TPL, Kucharczyk J. Human cortical activity during vestibular- and druginduced nausea detected using MSI. Ann NY Acad Sci 1996; 781: 670-2
10. Boess FG, Martin IL. Molecular biology of 5-HT receptors. Neuropharmacol 1994; 33: 257-317
11. Bruss M, Walstab J, Combrink S, Kurzwelly D, Bonisch H, Niesler B. Molecular pharmacology of 5-HT3 receptors. Pharmacol reports 2006 58; 253-72
12. Kilpatrick GJ, Bunce KT, Tyers MB. 5-HT3 receptors. Medicinal Res Rev 1990; 10:441-75
13. Barnes JM, Barnes NM, Costall B et al. Identification and distribution of 5-HT3 recognition sites within the human brainstem. Neurosci. Letts 1990; 111: 80-6
14. Higgins GA, Kilpatrick GJ, Bunce KT, Jones BJ, Tyers MB. 5-HT3 receptor antagonists injected into the area postrema inhibit cisplatin-induced emesis in the ferret. Br J Pharmacol 1989; 97: 247-55
15. Leslie RA, Reynolds DJM. Neurotransmitters and receptors in the emetic pathway. In: Andrews PLR, Sanger GJ, Editors. Emesis and anti-cancer therapy, mechanisms and treatment. London: Chapman and Hall, 1993; 91-107
16. Veyrat-Follet C, Farinotti R, Palmer JL. Physiology of chemotherapy-induced emesis and anti-emetic therapy. Drugs 1997; 53: 206-34
17. Naylor RJ, Rudd JA. Emesis and anti-emesis. In: Imperial cancer research fund. Cancer surveys volume 21: Palliative medicine. 1994: 117-135
18. Watson JW, Gonsalves SF, Fossa AA et al. The antiemetic effects of CP-99,994 in the ferret and the dog: role of the NK1 receptor. Br J Pharmacol 1995; 115: 84-94
19. Kilpatrick GJ, Jones BJ, Tyers MB. The distribution of specific binding of 5-HT3 receptor ligand (3H)GR65630 in rat brain using quantitative autoradiography. Neurosci Letts 1988; 94: 156-60
20. Andrews PLR, Davis CJ, Bingham S, Davidson HI, Hawthorn J, Maskell L. The abdominal visceral innervation and the emetic reflex: pathways, pharmacology and plasticity. Can J Physiol Pharmacol 1990; 68: 325-45
21. Fukada H, Koga T. The Botzinger complex as the pattern generator for retching and vomiting in the dog. Neurosci Res 1991; 12: 471-85
22. Leslie RA, Reynolds DJM, Andrews PLR, Grahame-Smith DG, Davis CJ, Harvey JM. Evidence for presynaptic 5-hydroxytryptamine-3 recognition sites on vagal afferent terminals in the brainstem of the ferret. Neuroscience 1990; 38: 667-31
23. Reynolds DJM, Leslie RA, Grahame-Smith DG, Harvey JM. Autoradiographic localisation of 5-HT3 receptor ligand binding in the cat brainstem. Neurochem Int 1991; 18: 69-73
24. Costall B, Domeney AM, Naylor RJ, Owera-Atepo JB, Rudd JA, Tattersall FD. Fluphenazine, ICS 205-930 and dl-fenfluramine differentially antagonise druginduced emesis in the ferret. Neuropharmacol 1990; 29: 453-62
25. Bhandari P, Bingham S, Andrews PLR. The neuropharmacology of loperamide-induced emesis in the ferret: The role of the area postrema, vagus, opiate and 5-HT3 receptors. Neuropharmacol 1992; 31: 735-42
26. Appadu BL, Lambert DG. Interaction of i.v. anaesthetic agents with 5-HT3 receptors. Br J Anaesth 1996; 76: 271-3
27. Parker RMC, Bentley KR, Barnes NM. Allosteric modulation of the 5-HT3 receptor: focus on alcohols and anaesthetic agents. Trends Pharmacol Sci 1996; 17: 95-9
28. Machu TK, Harris RA. Alcohols and anaesthetics enhance the function of 5-hydroxytryptamine3 receptors expressed in Xenopus laevis oocytes. J Pharmacol Exp Ther 1994; 271: 898-905
29. Johnston KD, Bentley KR, Stowe RL, Barnes NM. Ability of trichloroethanol to modify the 5-HT3 receptormediated depolarisation of the rat isolated vagus nerve. Br J Pharmacol 1995; 114: 275P
30. Barann M, Gothert M, Fink K, Bonisch H. Inhibition by anaesthetics of 14C guanidinium flux through voltagegated sodium channels and the cation channel of the 5-HT3 receptor of N1E-115 neuroblastoma cells. Naunyn-Schmied Arch Pharmacol 1993; 137: 125-32
31. Emerit MB, Riad M, Fattaccini CM, Hamon M. Characteristics of [14C] guanidinium accumulation in NG 108-15 cell exposed to serotonin 5-HT3 receptor ligands and substance P. J Neurochem 1993; 60: 2059-67
32. Peters JA, Malone HM, Lambert JJ. Ketamine potentiates 5-HT3 receptor-mediated currents in rabbit nodose ganglion neurones. Br J Pharmacol 1991; 103: 1623-5
33. Barann M, Dilger JP, Bonisch H, Dybek A, Urban BW. Inhibition of 5-HT3 receptors by propofol: equilibrium and kinetic measurements. Neuropharmacol 2000; 39: 1064-74
34. Andrews PLR, Davis CJ. The physiology of emesis induced by anticancer therapy. In: Reynolds DJM, Andrews PLR, Davis CJ, Editors. Serotonin and the scientific basis of anti-emetic therapy. Oxford: Oxford Clinical Communications, 1995; 25-49
35. Naylor RJ, Inall FC. The physiology and pharmacology of post-operative nausea and vomiting. Anaesthesia 1994; 49: 2-5
36. Bellville JW. Postanesthetic nausea and vomiting. Anesthesiology 1961; 22: 773-80
37. Watcha MF, White PF. Postoperative nausea and vomiting. Anesthesiology 1992; 77: 162-84
38. Koivuranta M, Laara E, Snare L, Alahuta S. A survey of postoperative nausea and vomiting. Anaesthesia 1997; 52: 443-9
39. Stadler M, Bardiau F, Seidel L, Albert A, Boogaerts. Difference in risk factors for postoperative nausea and vomiting. Anesthesiology 2003; 98: 46-52
40. Haigh CG, Kaplan LA, Durham JM, Dupeyron JP, Harmer M, Kenny GNC. Nausea and vomiting after gynaecological surgery: A meta-analysis of factors affecting their incidence. Br J Anaesth 1993; 71: 517-22
41. Sinclair DR, Chung F, Mezei G. Can postoperative nausea and vomiting be predicted? Anesthesiology 1999; 91: 109-18
42. Apfel CC, Kranke P, Katz MH et al. Volatile anaesthetics may be the main cause of early but not delayed postoperative vomiting: a randomised controlled trial of factorial design. Br J Anaesth 2002; 88: 659-68
43. Domino KB, Anderson EA, Polissar NL, Posner KL. Comparative efficacy and safety of ondansetron, droperidol, and metoclopramide for preventing postoperative nausea and vomiting: a meta-analysis. Anesth Analg 1999; 88: 1370
44. Gupta A, Wu CL, Elkassabany N, Krug CE, Parker SD, Fleisher LA. Does the routine prophylactic use of antiemetics affect the incidence of postdischarge nausea and vomiting following ambulatory surgery? Anesthesiology 2003; 99: 488-95
45. Monagle J, Barnes R, Goodchild C, Hewitt M. Ondansetron is not superior to moderate dose metoclopramide in the prevention of post-operative nausea and vomiting after minor gynaecological surgery. Eur J Anaesth 1997; 14: 604-9
46. Bolton CM, Myles PS, Carlin JB, Nolan T. Randomized, double-blind study comparing the efficacy of moderatedose metoclopramide and ondansetron for the prophylactic control of postoperative vomiting in children after tonsillectomy. Br J Anaesth 2007; 99: 699-703
47. Bolton CM, Myles PS, Nolan T, Sterne JA. Prophylaxis of postoperative vomiting in children undergoing tonsillectomy: a systematic review and meta-analysis. Br J Anaesth 2006; 97: 593-604
48. Läer S, Scholz J, Ritterbach C, Läer C, Rahme E. Association between increased 5-HIAA plasma concentrations and postoperative nausea and vomiting in patients undergoing general anaesthesia for surgery. Eur J Anaesthesiol 2001; 18: 833-8
49. Macario A, Dexter F, Lubarsky D. Meta-analysis of trials comparing postoperative recovery after anesthesia with sevoflurane or desflurane. Am J Health system Pharmacy 2005; 62: 63-8
50. Liu SS. Effects of bispectral index monitoring on ambulatory anesthesia: a meta-analysis of randomized controlled trials and a cost analysis. Anesthesiology 2004; 101: 311-315
51. Tramer MR, Reynolds DJM, Moore RA, McQuay HJ. Efficacy, dose-response, and safety of ondansetron in prevention of postoperative nausea and vomiting: A quantitative systematic review of randomised placebocontrolled trials. Anesthesiology 1997; 87: 1277-1289
52. Tramer MR, Moore RA, Reynolds DJM, McQuay HJ. A quantitative systematic review of ondansetron in treatment of established postoperative nausea and vomiting. BMJ 1997; 314: 1088-91
53. White PF, Watcha MF. Postoperative nausea and vomiting: Prophylaxis versus treatment. Anesth Analg 1999; 89: 1337-39
54. Sneyd JR, Carr A, Byrom WD, Bilski T. A meta-analysis of nausea and vomiting following maintenance of anaesthesia with propofol or inhalational agents. Eur J Anaesth 1998; 15: 433-445
55. Apfel CC, Kortilla K, Abdalla M et al. A factorial trial of six interventions for the prevention of postoperative nausea and vomiting. NEJM 2004; 350: 2441-51
56. Baxendale BR, Vater M, Lavery KM. Dexamethasone reduces pain and swelling following extraction of third molar teeth. Anaesthesia 1993; 48: 691-964
57. Tavorath R, Hesketh PJ. Drug treatment of chemotherapy-induced delayed emesis. Drugs 1996; 52: 639-48
58. Henzi I, Walder B, Tramer MR. Dexamethasone for the prevention of postoperative nausea and vomiting: A quantitative systematic review. Anesth Analg 2000; 90: 186-94
59. Rusch D, Arndt C, Martin H, Kranke P. The addition of dexamethasone to dolasetron or haloperidol for treatment of established postoperative nausea and vomiting. Anaesthesia 2007; 62: 810-7
60. Thomas R, Jones N. Prospective randomised, doubleblind comparative study of dexamethasone, ondansetron, and ondansetron plus dexamethasone as prophylactic antiemetic therapy in patients undergoing day-case gynaecological surgery. Br J Anaesth 2001; 87: 588-92
61. Morimoto M, Morita N, Ozawa H, Yokoyama K, Kawata M. Distribution of glucocorticoid receptor immunoreactivity and mRNA in the rat brain: an immunohistochemical and in-situ hybridisation study. Neurosci Res 1996; 26: 235-69
62. Ho CM, Ho ST, Wang JJ, Tsai SK, Chai CV. Dexamethasone has a central anti-emetic mechanism in decerebrated cats. Anesth Analg 2004; 99: 734-39
63. Sam TSW, Ngan MP, Riendeau D, Robichaud A, Rudd JA. Action of cyclooxygenase inhibitors and a leukotriene biosynthesis inhibitor on cisplatin-induced acute and delayed emesis in the ferret. J Pharmacol Sci 2007; 103: 189-200
64. Eiler H, Paddleford R. Induction of intestinal evacuation or vomition (or both) in the dog by prostaglandin F2alpha injection: clinical potential. Am J Vet Res 1979; 40: 1731-2
65. Kan KKW, Jones RL, Ngan MP, Rudd JA. Actions of prostanoids on the emetic reflex of Suncus murinus (the house musk shrew). Eur J Pharmacol 2003; 477: 247-51
66. Kan KKW, Rudd JA, Wai MK. Differential action of antiemetic drugs on defecation and emesis induced by prostaglandin E2 in the ferret. Eur J Pharmacol 2006; 544: 1539-59
67. Girod V, Dapzol J, Bouvier M, Grelot L. The COX inhibitors indomethacin and meloxicam exhibit antiemetic activity against cisplatin-induced emesis in piglets. Neuropharmacol 2002; 42: 428-36
68. Cheng FHM, Andrews PLR, Moreaux B, Ngan MP, Rudd JA, Sam TSW, Wai MK, Wan C. Evaluation of the antiemetic potential of anti-migraine drugs to prevent resinferatoxin-induced emesis in Suncus murinus (house musk shrew). Eur J Pharmacol 2005; 508: 231-8
69. Abraham I, Juhasz G, Kekesi KA, Kovacs KJ. Effect of intrahippocampal dexamethasone on the levels of amino acid transmitters and neuronal excitability. Brain Res 1996; 733: 56-63
70. Young S. Mechanism of decline in rat brain 5-hydroxytryptamine after induction of liver tryptophan pyrrolase by hydrocortisone: roles of tryptophan catabolism and kynurenine synthesis. Br J Pharmacol 1981; 74: 695-700
71. Sam TSW, Cheng JTY, Johnston KD, Kan KKW, Ngan MP, Rudd JA, Wai MK, Yeung JHK. Action of 5-HT3 receptor antagonists and dexamethasone to modify cisplatin-induced emesis in Suncus murinus (house musk shrew). Eur J Pharmacol 2003; 472: 135-45
72. Suzuki T, Sugimoto M, Koyama H, Mashimo T, Uchida I. Inhibitory effect of glucocorticoids on human cloned 5-Hydroxytryptamine3A receptor expressed in Xenopus oocytes. Anesthesiology 2004; 101: 660-5
73. Rudd JA, Naylor RJ. Opioid receptor involvement in emesis and anti-emesis. In: Reynolds DJM, Andrews PLR, Davis CJ, Editors. Serotonin and the scientific basis of anti-emetic therapy. Oxford: Oxford clinical communications, 1995; 208-19
74. Borison HL. Effect of ablation of medullary emetic chemoreceptor trigger zone on vomiting responses to cerebral intraventricular injection of adrenaline, apomorphine and pilocarpine in the cat. J Physiol 1959; 147: 172-7
75. Koga T, Qu R, Fukada H. The central pattern generator for vomiting may exist in the reticular area dorsomedial to the retrofacial nucleus in dogs. Exp Brain Res 1998; 118: 139-47
76. Kamath B, Curran J, Hawkey C, Beattie A, Gorbutt N, Guiblin H, Kong A. Anaesthesia, movement and emesis. Br J Anaesth 1990; 64: 728-30
77. Pedigo NW, Brizzee KR. Muscarinic cholinergic receptors in area postrema and brainstem areas regulating emesis. Brain Res Bulletin 1985; 14: 169-77
78. Salmenpera M, Kuoppamaki R, Salmenpera A. Do anticholinergic agents affect the occurrence of postanaesthetic nausea? Acta Anaesth Scand 1992; 36: 445-8
79. Chhiber AK, Lustik SJ, Thakur R, Francisco DR, Fickling KB. Effects of anticholinergics on postoperative vomiting, recovery and hospital stay in children undergoing tonsillectomy with or without adenoidectomy. Anesthesiology 1999; 90: 967-700
80. Harmer M. Pharmacological intervention in postoperative nausea and vomiting: scientific evidence and expert opinion for anti-emetic therapy for prophylaxis and management. In: Strunin L, Rowbotham D, Miles A, Editors. The prevention and management of postoperative nausea and vomiting 2nd ed. London: Aesculapius medical, 2003; 53-69
81. Leslie RA, Murphy KM, Robertson HA. Nodose ganglionectomy selectively reduces muscarinic cholinergic and delta opioid binding sites in the dorsal vagal complex of the cat. Neuroscience 1989; 32: 481-92
82. Andrews PLR, Rapeport WG, Sanger GJ. Neuropharmacology of emesis induced by anti-cancer therapy. Trends Pharmacol Sci 1988; 9: 334-41
83. Bountra C, Gale JD, Gardner CJ, Jordan CC, Kilpatrick GJ, Twissell DJ, Ward P. Towards understanding the aetiology and pathophysiology of the emetic reflex: novel approaches to antiemetic drugs. Oncology 1996; 53: 102-9
84. Andrews PLR, Davis CJ. The mechanism of emesis induced by anti-cancer therapies. In: Andrews PLR, Sanger GJ, Editors. Emesis and anti-cancer therapy, mechanisms and treatment.London: Chapman and Hall, 1993; 113-61
85. Hough M, Sweeney B. The influence of smoking on postoperative nausea and vomiting. Anaesthesia 1998; 53: 932-3
86. Ionescu D, Badescu C, Acalovschi L. Nicotine patch for the prevention of postoperative nausea and vomiting: A prospective randomised trial. Clin Drug Invest 2007; 27: 559-64
87. Srivastava ED, Russell MA, Feyerabend C, Masterson JG, Rhodes J. Sensitivity and tolerance to nicotine in smokers and nonsmokers. Psychopharmacol 1991; 105: 63-8
88. Whalen F, Sprung J, Burkle CM, Schroeder DR, Warner DO. Recent smoking behaviour and postoperative nausea and vomiting. Ambulatory Anaesth 2006; 103: 70-5
89. Chimbira W, Sweeney BP. The effect of smoking on postoperative nausea and vomiting. Anaesthesia 2000; 55: 540-4
90. Kharasch ED, Thummel KE. Identification of cytochrome P450 2E1 as the predominant enzyme catalyzing human liver microsomal defluorination of sevoflurane, isoflurane and methoxyflurane. Anesthesiology 1993; 79: 795-807
91. Bhargava KP, Dixit KS, Palit G. Nature of histamine receptors in the emetic chemoreceptor trigger zone. Br J Pharmacol 1976; 57: 211-3
92. Khalil S, Philbrook L, Rabb M, Wells L, Aves T, Villanueva G, Amhan M, Chuang AZ, Lemak NA. Ondansetron/ promethazine combination or promethazine alone reduces nausea and vomiting after middle ear surgery. J Clin Anesth 1999; 11: 596-600
93. Honkavaara P. Effect of ondansetron on nausea and vomiting after middle ear surgery during general anaesthesia. Br J Anaesth 1995; 76: 316-8
94. Kranke P, Morin AM, Roewer N, Hinnerk W, Eberhart LH. The efficacy and safety of transdermal scopolamine for the prevention of postoperative nausea and vomiting: A quantitative systematic review. Anesth Analg 2002; 95: 133-43
95. Berkowitz BA, Ngai SH, Finck AD. Nitrous oxide "analgesia": resemblance to opiate action. Science 1976; 194: 967-8
96. Berkowitz BA, Finck AD, Ngai SH. Nitrous oxide analgesia: reversal by naloxone and development of tolerance. J Pharmacol Exp Ther 1977; 203: 539-47
97. Gillman MA, Lichtigfeld FJ. Pharmacology of psychotropic analgesic nitrous oxide as a multipotent opioid agonist. Int J Neurosci 1994; 76: 5-12
98. Divatia JV, Vaidya JS, Badwe RA, Hawaldar RW. Omission of nitrous oxide during anesthesia reduces the incidence of postoperative nausea and vomiting: A meta-analysis. Anesthesiology 1996; 85: 1055-62
99. Tramer M, Moore A, McQuay H. Omitting nitrous oxide in general anaesthesia: meta-analysis of intraoperative awareness and postoperative emesis in randomized controlled trials. Br J Anaesth 1996; 76: 186-93